Polycystic Ovary Syndrome and Insulin-Resistant Hyperinsulinemia
September 2001
in “
Journal of the American Academy of Dermatology
”
![Image of study](/images/research/1d52ff8b-5e0e-471d-8ace-9037e656e108/medium/30543.jpg)
TLDR Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.
The document from 2001 discusses polycystic ovary syndrome (PCOS), which is largely synonymous with chronic unexplained hyperandrogenemia, a condition responsible for about 95% of hyperandrogenism in women. PCOS is characterized by a variety of classic and nonclassic forms, potentially with different genetic causes. The condition's hyperandrogenism is thought to stem from a dysregulation of steroidogenesis due to an imbalance of factors that modulate trophic hormone action. Hyperinsulinemia, caused by insulin resistance, is a significant contributing factor in many PCOS cases, leading to hyperandrogenemia in those with a genetic predisposition by revealing latent steroidogenesis regulation issues. Interestingly, a gene associated with PCOS may manifest as pattern baldness in males. Insulin, along with androgens, also influences the development of pilosebaceous units. The use of antidiabetic insulin-lowering medications may improve ovarian function and androgen levels in PCOS patients, but it is unclear if these treatments will affect pilosebaceous unit symptoms.